CBS News editor in chief Bari Weiss is reportedly applying an “intense level of editorial scrutiny” to another “60 Minutes” report — this one involving Anderson Cooper. The stalled report is an ...

A 13-minute segment about Venezuelan men deported by the Trump administration had been pulled at the last minute by CBS News’s editor in chief, Bari Weiss. By Michael M. Grynbaum CBS News faced a ...

A version of this article first appeared in the Reliable Sources newsletter. You can sign up for free right here. Nearly a month after CBS News editor in chief Bari Weiss triggered a scandal by ...

Bari Weiss met this week with top “60 Minutes” editors in an effort to advance the newsmagazine’s pulled story on Venezuelans being deported by the Trump administration to an El Salvadorian prison, ...

“60 Minutes” on Sunday aired its story about Trump administration deportations that was abruptly pulled from the newsmagazine’s lineup a month ago, a move that had triggered an internal battle about ...

The “60 Minutes” story on the El Salvador prison that led to a rocky start for CBS News Editor in Chief Bari Weiss made it to air Sunday. The segment, “Inside CECOT,” detailed the Trump administration ...

Add Yahoo as a preferred source to see more of our stories on Google. MAGA-friendly CBS editor-in-chief Bari Weiss is reportedly personally stalling a new 60 Minutes segment that has the potential to ...

The defense plans to bring the noise this Saturday in Chicago. Find out more in this edition of Packers Daily. Green Bay Packers TE Tucker Kraft found himself atop NFL rankings for yards after catch ...

CBS Evening News embedded with Homeland Security Secretary Kristi Noem on Tuesday as part of the ongoing DHS crackdown on alleged fraud and immigration violations in the Minneapolis area. The Trump ...

CBS' "60 Minutes" finally aired its controversial segment on migrants deported to El Salvador's maximum-security prison, CECOT, Sunday night after being abruptly pulled off the air last month. In a ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...